Champions Oncology Inc.
CSBR | NASDAQ
$4.81
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$4.81
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
36.8
+7.6 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #606/1028 (Top 59%)
Key Statistics
Market Data
Market Cap $66.95M
1D Range
4.76 4.95
52W Range
4.69 7.80
Valuation (TTM)
PE -60.89
PB 17.20
EV/EBITDA 164.56
Valuation (NTM)
Forward PE 48.40
Forward PEG 3.65
Price Target $12.00
Cash Flow
FCF Yield -9.2%
SBC Adj. FCF Yield -11.8%
SBC Impact -29.3%
Margins
Gross Margin 49.3%
Operating Margin -1.7%
FCF Margin -10.1%
Growth (CAGR)
Revenue 3Y | 5Y 4.8% |
7.3%
Dil EPS 3Y | 5Y 198.8% |
41.6%
FCF 3Y | 5Y -689.0% |
-1468.7%
Returns
ROA -3.4%
ROE -27.9%
ROIC -6.8%
Financial Health
Net Cash
$3.49M
Current Ratio 1.03
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of onco...
Sector Healthcare
Industry Biotechnology
Employees 214
IPO Date Feb 2, 2007
Website www.championsoncology.com
Fiscal Year May - April
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CSBR